Skip to main content

Newswise – LOS ANGELES (August 23, 2022) – The Cedars-Sinai Accelerator welcomes 10 health technology startups from around the world to its eighth class of accelerators. Companies are creating a variety of healthcare solutions, from culturally appropriate digital mental health services to wearable devices that help patients manage chronic asthma.

After going fully virtual in 2020 in response to the COVID-19 pandemic, the accelerator launched a hybrid model in 2021. Continuing this year, the hybrid model allows business leaders to choose to attend Cedars in person. -Sinai or virtually.

During the three-month tenure, company representatives work with physicians, researchers, and administrators to understand how their products and solutions work in a real-world environment to benefit patients, clinicians, and hospitals.

“Promising new technologies and advances in the digital space can drive positive changes in the way healthcare is experienced,” said James Laur, JD, vice president of intellectual property and general manager of Cedars- Sinai Technology Ventures, and one of the founders of the accelerator. . “As one of the top-ranked hospitals in the nation, Cedars-Sinai recognizes the importance of innovation. Bringing this new class of business into the accelerator allows us to partner with entrepreneurs who are working on problems that we are trying to solve as a health care provider.

Each company accepted into the program will receive a $100,000 investment from Cedars-Sinai. At the end of the three-month program, business leaders will share their progress with an audience of investors, mentors, potential customers and members of the media during a demo day.

“Providing strategic and operational insights early in development is critical to enabling healthcare innovations,” said Nirdesh K. Gupta, PhD, CEO of Cedars-Sinai Technology Ventures. “Our accelerator provides this vital partnership to start-up companies developing the solutions that healthcare systems need to deliver high-quality, safe and effective patient care.”

The eighth class Cedars-Sinai Accelerator includes:

Follower Health—Using voice and facial recognition software, Acolyte creates bespoke video content, including preventative health care, pre- and post-visit training, reminders and more, which is transmitted securely. patient safety on the device of their choice. Patients using the interactive videos can take immediate action, resulting in better outcomes, such as reduced readmissions, better medication adherence, and increased patient satisfaction.

Device Health—Aevice Health has created an AI-powered wearable device that continuously monitors key biomarkers of respiratory diseases like asthma. Chronic diseases such as asthma account for 25% of emergency room visits, mainly due to the lack of objective data from patients to help them assess the progression of the disease at home. With this device, the company’s goal is to empower patients to manage their condition, optimizing the affordability of healthcare and hospital resources.

Help to—Aidin created a digital healthcare workflow platform that helps streamline and structure hospital workflows, helping case managers complete daily tasks faster and transfer patients to providers trusted care. The company aims to help reduce patient length of stay, manage staff assignments and deal with delays in real time.

Candlelit Therapy Inc.—Candlelit Therapy Inc. is a digital mental health provider for underserved new and expectant parents at risk for perinatal mood and anxiety disorders. Candlelit Therapy’s Perinatal Mental Health Service is grounded in cultural competency, celebrates black identity, and provides an easy way to access culture-based treatment while supporting obstetricians, nurse-midwives, and birth attendants to proactively screen for and manage life-threatening conditions in a more culturally appropriate and assertive manner. .

GattaCo—GattaCo’s A-PON Plasma Separator eliminates the need for bulky equipment currently required for most blood tests. The A-PON is a self-collection device that uses finger blood to produce laboratory-grade liquid plasma. Plasma is the most widely used sample type in clinical laboratory testing to detect and monitor medical conditions, diseases, or therapeutic responses.

HealthLeap Inc.—HealthLeap Inc. offers an artificial intelligence-based clinical nutrition application, NutriLeap, which helps healthcare professionals prevent and treat malnutrition. The app helps hospital dietitians perform accurate nutritional calculations and provides recommendations based on the latest clinical guidelines.

Lamp—Luminare has created a digital platform that aims to accelerate the speed of sepsis detection to save lives, reduce alert fatigue, and increase revenue through improved clinical documentation.

Gap—Shift provides learner-focused nursing education through virtual reality, real-time adjustments, and insights. The company’s growing library focuses on promoting health equity, nursing onboarding, infection prevention and mandatory educations. ShifBias, a women-founded company, aims to reduce the time, money, and staff resources needed to train nurses and give nurses the tools to improve patient outcomes.

siimee—Siimee has created a recruitment platform that directly connects job seekers and employers by creating a one-to-one matching experience, highlighting users’ backgrounds and interests against opportunities, while educating employers with the goal of eliminating early biases that historically occur in recruitment. treat.

Synth—Syntho provides AI-based privacy-enhancing technology to generate anonymous synthetic data points. These data points are then used by medical researchers in a variety of research projects.

Read more in Discoveries: Pandemic DIY supply